Newly Diagnosed
Parkinsons Disease

  • young onset - biologically fit
  • minimal co-morbidities
  • mild symptoms

  • biologically frail
  • co-morbidities
  • cognitive impairment

  • monoamine oxidase inhibitor (rasagiline, selegiline)
  • dopamine agonist (ropinirole, rotigotine, pramipexole)

  • l-dopa therapy (co-beneldopa, co-caredopa)
  • comt inhibitor (entacapone, tolcapone)

  • L-DOPA therapy (co-beneldopa, co-caredopa)
  • COMT inhibitor (entacapone, tolcapone)

  • monoamine oxidase inhibitor (rasagiline, selegiline)
  • dopamine agonist (ropinirole, rotigotine, pramipexole